ÉTUDE PRODIGE 91-UNICANCER-UCGI 46 TRIFLUOX-DP - En cours de lancement
Title
Safety of Trifluridine/tipiracil as replacement of fluoropyrimidines (5-fluorouracil and capecitabine) based chemotherapy as first line metastatic colorectal or gastroesophageal cancer regimens in patients with dihydropyrimidine dehydrogenase deficiency
Coordonateur
SAMALIN E
Co-Coordonateur
Promoteur
UNICANCER (UCGI)Localisation
Cancer de l’Œsophage et de l’Estomac
Phase
IIR
NOMBRE DE PATIENTS ATTENDU
73
Statut
En cours de lancement
CONTACT
c-dumasbonnetain@unicancer.fr